Vol. 45 No. 6 (2006): Acta Oncologica

Articles

• Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: An evaluation of 212 cases

  Heikki Luukkaa, Pekka Klemi, Ilmo Leivo, Tero Vahlberg, Reidar Grénman

  669-675

  Published: 2006-01-01

  • PDF

• 3-D conformal treatment of prostate cancer to 74 Gy vs. high-dose-rate brachytherapy boost: A cross-sectional quality-of-life survey

  Dirk Vordermark, Jörn Wulf, Klaus Markert, Kurt Baier, Oliver Kölbl, Gabriele Beckmann, Klaus Bratengeier, Michael Noe, Georg Schön, Michael Flentje

  708-716

  Published: 2006-01-01

  • PDF

• FDG-PET in a patient with gastric MALT lymphoma

  Jean-Dean Liu, Cheng-Jeng Tai, Chun-Chao Chang, Yun-Ho Lin, Chung-Huei Hsu

  750-752

  Published: 2006-01-01

  • PDF

• Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis

  Christer Ericsson, Bo Franzén, Monica Nistér

  643-661

  Published: 2006-01-01

  • PDF

• Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy

  Krystyna Serkies, Andrzej Badzio, Jacek Jassem

  695-701

  Published: 2006-01-01

  • PDF

• Chemoradiotherapy of anal cancer is feasible in elderly patients: Treatment results of mitomycin–5-FU combined with radiotherapy at Helsinki University Central Hospital 1992–2003

  Kauko Saarilahti, Päivi Arponen, Leila Vaalavirta, Mikko Tenhunen, Carl Blomqvist

  736-742

  Published: 2006-01-01

  • PDF

• p16INK4a and laminin-5γ2 chain expression during the progression of cervical neoplasia

  Jian-Liu Wang, Sonia Andersson, Xidan Li, Ann-Cathrin Hellström, Gert Auer, Tord Ångström, Mikael S. Lindström, Keng-Ling Wallin

  676-684

  Published: 2006-01-01

  • PDF

• Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy

  Theodore S. Hong, Wolfgang A. Tomé, Hazim Jaradat, Bridget M. Raisbeck, Mark A. Ritter

  717-727

  Published: 2006-01-01

  • PDF

• Plasma TGFβ1 during pelvic radiotherapy for gynaecological malignancy

  R. Coker, S. Kiani-Alikhan, A. Stewart, C. Pusey, R. G. Dale, B. Jones

  753-754

  Published: 2006-01-01

  • PDF

• Insights into a complex group of neoplastic disease: Advances in histopathologic classification and molecular pathology of salivary gland cancer

  Ilmo Leivo

  662-668

  Published: 2006-01-01

  • PDF

• Radiation dose to laterally transposed ovaries during external beam radiotherapy for cervical cancer

  Michael Mazonakis, John Damilakis, Haris Varveris, Nicholas Gourtsoyiannis

  702-707

  Published: 2006-01-01

  • PDF

• FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre.

  Maria Bjurberg, Anita Gustavsson, Tomas Ohlsson, Eva Brun

  743-749

  Published: 2006-01-01

  • PDF

• 2-DE protein expression in endometrial carcinoma

  Caroline Lundgren, Johanna Lahmann, Susanne Becker, Uwe Roblick, Kjell Schedvins, Karolina Boman, Bo Frankendal, Britta Nordström, Gert Auer

  685-694

  Published: 2006-01-01

  • PDF

• Chemoradiotherapy in patients with anal cancer: Impact of length of unplanned treatment interruption on outcome

  Andreas Meyer, Jürgen Meier Zu Eissen, Johann H. Karstens, Michael Bremer

  728-735

  Published: 2006-01-01

  • PDF